Showing 61 - 80 results of 115 for search '"systemic sclerosis"', query time: 0.07s Refine Results
  1. 61
  2. 62
  3. 63

    Circulating Tissue Inhibitor of Matrix Metalloproteinase-4 (TIMP-4) in Systemic Sclerosis Patients with Elevated Pulmonary Arterial Pressure by Gialafos J. Elias, Moyssakis Ioannis, Psaltopoulou Theodora, Papadopoulos P. Dimitrios, Perea Despoina, Vlasis Kostantinos, Kostopoulos Charalampos, Votteas Vassilios, Sfikakis P. Petros

    Published 2008-01-01
    “…Decreased levels of matrix metalloproteinases (MMPs) or excess levels of their tissue inhibitors (TIMPs) may contribute to dysregulation of extracellular matrix turnover in systemic sclerosis (SSc). In a cross-sectional study of 106 SSc patients, we measured serum levels of TIMP-4 which is preferentially expressed in cardiovascular structures and searched for correlations with simultaneously performed echocardiography measurements of pulmonary artery systolic pressure (PASP), myocardial performance, and pulmonary function tests. …”
    Get full text
    Article
  4. 64

    When the Benign Pneumatosis Intestinalis Becomes No Longer Benign: A Rare Case of Bowel Perforation in a Patient with Systemic Sclerosis by Jian Guan, Alvina Munaf, Alric V. Simmonds, Irteza Inayat

    Published 2018-01-01
    “…Systemic sclerosis is a multisystem disease featured with autoimmunity and organ fibrosis. …”
    Get full text
    Article
  5. 65
  6. 66
  7. 67
  8. 68

    Assessment of T Regulatory Cells and Expanded Profiling of Autoantibodies May Offer Novel Biomarkers for the Clinical Management of Systemic Sclerosis and Undifferentiated Connective Tissue Disease by Paola Cordiali-Fei, Anna Mussi, Giovanna D'Agosto, Elisabetta Trento, Valentina Bordignon, Silvana Trincone, Antonella Vento, Isabella Sperduti, Antonio Cristaudo, Fabrizio Ensoli

    Published 2013-01-01
    “…In order to identify disease biomarkers for the clinical and therapeutic management of autoimmune diseases such as systemic sclerosis (SSc) and undifferentiated connective tissue disease (UCTD), we have explored the setting of peripheral T regulatory (T reg) cells and assessed an expanded profile of autoantibodies in patients with SSc, including either limited (lcSSc) or diffuse (dcSSc) disease, and in patients presenting with clinical signs and symptoms of UCTD. …”
    Get full text
    Article
  9. 69
  10. 70
  11. 71
  12. 72

    Fifty-Two-Week Results of Clinical and Imaging Assessments of a Patient with Rheumatoid Arthritis Complicated by Systemic Sclerosis with Interstitial Pneumonia and Type 1 Diabetes despite Multiple Disease-Modifying Antirheumatic Drug Therapy That Was Successfully Treated with Baricitinib: A Novel Case Report by Yuya Fujita, Masao Nawata, Atsushi Nagayasu, Kazuki Someya, Kazuyoshi Saito, Yoshiya Tanaka

    Published 2019-01-01
    “…To date, no studies have demonstrated the effectiveness of baricitinib on systemic sclerosis or type 1 diabetes. We report that baricitinib was effective for systemic sclerosis and type 1 diabetes, as well as for rheumatoid arthritis, for up to 52 weeks.…”
    Get full text
    Article
  13. 73

    Autologous Fat Grafting in the Treatment of Facial Scleroderma by Mehdi Gheisari, Arman Ahmadzadeh, Nilofar Nobari, Behzad Iranmanesh, Nikoo Mozafari

    Published 2018-01-01
    “…Systemic sclerosis (SSc) is a rare systemic autoimmune disease, characterized by progressive cutaneous and internal organ fibrosis. …”
    Get full text
    Article
  14. 74

    The Microbiome in Connective Tissue Diseases and Vasculitides: An Updated Narrative Review by Rossella Talotta, Fabiola Atzeni, Maria Chiara Ditto, Maria Chiara Gerardi, Piercarlo Sarzi-Puttini

    Published 2017-01-01
    “…The PubMed database was searched for articles using combinations of words or terms that included systemic lupus erythematosus, systemic sclerosis, autoimmune myositis, Sjögren’s syndrome, undifferentiated and mixed CTD, vasculitis, microbiota, microbiome, and dysbiosis. …”
    Get full text
    Article
  15. 75

    Neutrophil-to-lymphocyte ratio: association with microcirculatory changes detected by nailfold capillaroscopy in scleroderma patients and its relation to disease severity by Rasha M. Hammoda, Nermin H. El-Gharbawy, Ahmed A. Khalifa, Amira A. Moharram, Rahma A. Elziaty

    Published 2025-01-01
    “…Conclusion High N/L ratio as a marker of inflammation was found to reflect severity of systemic sclerosis and is associated with larger capillary diameter and lower capillary number in nailfold capillaroscopy. …”
    Get full text
    Article
  16. 76

    Phaeochromocytoma Mimicking Scleroderma by Joan Joo-Ching Khoo, Edward John Pratt

    Published 2011-01-01
    “…We describe a patient with adrenal phaeochromocytoma who presented with peripheral vasospasm and ischaemia and other manifestations mimicking features of systemic sclerosis, which resolved after resection of the tumor. …”
    Get full text
    Article
  17. 77

    Automatic assessment of nailfold capillaroscopy software: a pilot study by Olga Elżbieta Brzezińska, Krzysztof Andrzej Rychlicki-Kicior, Joanna Samanta Makowska

    Published 2024-11-01
    “…Introduction Capillaroscopy is a simple method of nailfold capillary imaging, used to diagnose diseases from the systemic sclerosis spectrum. However, the assessment of the capillary image is time-consuming and subjective. …”
    Get full text
    Article
  18. 78

    Morphoea with Myositis: A Rare Association by Mary Sommerlad, Richard Bull, Claire Gorman

    Published 2011-01-01
    “…Although the association of myositis with diffuse systemic sclerosis is well described, the link with localised scleroderma (morphoea) and myositis has not been described.…”
    Get full text
    Article
  19. 79

    Impact of Scleroderma‐Associated Autoantibodies on Clinical Outcome Assessments: Post Hoc Analysis From a Randomised, Double‐blind, Placebo‐controlled, Phase 3 Trial of Tocilizumab... by Basmah Al Dulaijan, Suiyuan Huang, Celia J. F. Lin, Christopher P. Denton, Dinesh Khanna

    Published 2025-01-01
    “…Objective Scleroderma‐associated autoantibodies (SSc‐Abs) are specific in participants (pts) with systemic sclerosis and are associated with organ involvement. …”
    Get full text
    Article
  20. 80

    The pathogenesis of scleroderma by Latika Gupta, Sakir Ahmed, Abhishek Zanwar

    Published 2017-01-01
    “…Systemic sclerosis (SSc) results from the complex interplay between the immune system, vasculature and tissue-repair mechanisms. …”
    Get full text
    Article